- Home
- Publications
- Publication Search
- Publication Details
Title
Nicotinic acid: clinical considerations
Authors
Keywords
-
Journal
Expert Opinion On Drug Safety
Volume 11, Issue 4, Pages 551-564
Publisher
Informa Healthcare
Online
2012-05-08
DOI
10.1517/14740338.2012.682981
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acetylsalicylic Acid Reduces Niacin Extended-Release-Induced Flushing in Patients with Dyslipidemia
- (2013) Roopal B. Thakkar et al. American Journal of Cardiovascular Drugs
- Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
- (2011) Martina Lukasova et al. JOURNAL OF CLINICAL INVESTIGATION
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic Acid
- (2010) Carlos Hernandez et al. Cell Metabolism
- Do Statins Beneficially or Adversely Affect Glucose Homeostasis?
- (2010) Michael S. Kostapanos et al. Current Vascular Pharmacology
- Nicotinic acid– and monomethyl fumarate–induced flushing involves GPR109A expressed by keratinocytes and COX-2–dependent prostanoid formation in mice
- (2010) Julien Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6–HDL and LDL Treatment Strategies in Atherosclerosis)
- (2010) Todd C. Villines et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association between extended-release niacin treatment and glycemic control in patients with type 2 diabetes mellitus: analysis of an administrative-claims database
- (2010) Baishali M. Ambegaonkar et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease
- (2009) Darbie Maccubbin et al. AMERICAN JOURNAL OF CARDIOLOGY
- Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis
- (2009) Eric Bruckert et al. ATHEROSCLEROSIS
- Niacin improves renal lipid metabolism and slows progression in chronic kidney disease
- (2009) Kyu-hyang Cho et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy
- (2009) Sajoscha A. Sorrentino et al. CIRCULATION
- Blood pressure-lowering effects of extended-release niacin alone and extended-release niacin/laropiprant combination: A post hoc analysis of a 24-week, placebo-controlled trial in dyslipidemic patients
- (2009) Harold E. Bays et al. CLINICAL THERAPEUTICS
- Whatʼs the deal with niacin development: is laropiprant add-on therapy a winning strategy to beat a straight flush?
- (2009) Harold E Bays et al. CURRENT OPINION IN LIPIDOLOGY
- Standards of Medical Care in Diabetes--2010
- (2009) DIABETES CARE
- The mechanism and mitigation of niacin-induced flushing
- (2009) V. S. Kamanna et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Effects of Aspirin When Added to the Prostaglandin D2Receptor Antagonist Laropiprant on Niacin-Induced Flushing Symptoms
- (2009) Victor Dishy et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Niacin on Glucose Control in Patients With Dyslipidemia
- (2009) Ronald B. Goldberg et al. MAYO CLINIC PROCEEDINGS
- The Effect of Body Mass Index on Fasting Blood Glucose and Development of Diabetes Mellitus After Initiation of Extended-Release Niacin
- (2009) Ardelle Libby et al. Metabolic Syndrome and Related Disorders
- Comparison of the Safety and Efficacy of a Combination Tablet of Niacin Extended Release and Simvastatin vs Simvastatin Monotherapy in Patients With Increased Non–HDL Cholesterol (from the SEACOAST I Study)
- (2008) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- Extended-Release Niacin Alters the Metabolism of Plasma Apolipoprotein (Apo) A-I and ApoB-Containing Lipoproteins
- (2008) Stefania Lamon-Fava et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Niacin Increases HDL by Reducing Hepatic Expression and Plasma Levels of Cholesteryl Ester Transfer Protein in APOE*3Leiden.CETP Mice
- (2008) José W.A. van der Hoorn et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Niacin inhibits vascular oxidative stress, redox-sensitive genes, and monocyte adhesion to human aortic endothelial cells
- (2008) Shobha H. Ganji et al. ATHEROSCLEROSIS
- Extended-Release Niacin/Laropiprant: Reducing Niacin-Induced Flushing to Better Realize the Benefit of Niacin in Improving Cardiovascular Risk Factors
- (2008) John F. Paolini et al. CARDIOLOGY CLINICS
- Measuring flushing symptoms with extended-release niacin using the flushing symptom questionnaire©: results from a randomised placebo-controlled clinical trial
- (2008) J. F. Paolini et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia
- (2008) D. Maccubbin et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Flushing and the HDL-C response to extended-release niacin
- (2008) Allen J. Taylor et al. Journal of Clinical Lipidology
- Niacin inhibits surface expression of ATP synthase β chain in HepG2 cells: implications for raising HDL
- (2008) Lin-Hua Zhang et al. JOURNAL OF LIPID RESEARCH
- Is raising HDL a futile strategy for atheroprotection?
- (2008) Tisha Joy et al. NATURE REVIEWS DRUG DISCOVERY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More